NCT02606799View on ClinicalTrials.gov

Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Inflammation
Interventions
DEVICE

CytoSorb cytokine elimination

Hemoperfusion using continuous veno-venous hemofiltration (citrate regional anticoagulation) with CytoSorb cytokine elimination over a period of 48h immediately following admission to the intensive care unit

Trial Locations (1)

20251

University Medical Center Hamburg-Eppendorf, Hamburg

Sponsors

Collaborators (1)

CytoSorbents, Inc
All Listed Sponsors
collaborator

CytoSorbents, Inc

INDUSTRY

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER